The company had a very short period of time to announce a new Chairman and Director to comply with the listing rules.
It makes sense that they lookined internally to do so, and the CFO is a suitable candidate.
I have no doubt that the non-exec they end up appointing will have suitable skills and experience, and given the trial results are only weeks away the ability to attract a high calibre person as a non-exec will significantly increase very soon.
I like todays announcement. It mentions that Steve is there to lead through the commercialisation process, which is signalling that there is a product to commercialise... ie the Phase III results will be ok.
Time to raid the piggy bank again me thinks. This company is way too cheap
- Forums
- ASX - By Stock
- EMS
- lost opporyunity - no new blodd on the board
lost opporyunity - no new blodd on the board, page-5
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMS (ASX) to my watchlist
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online